7Baggers
 (NVCT) Volatility Zones as Tactical Triggers  news.stocktradersdaily.com Wed, 12 Nov 2025 16:52:02 GMT
 Director of Nuvectis Pharma Juan Sanchez Buys 20% More Shares  Yahoo Finance Sat, 08 Nov 2025 08:00:00 GMT
 HC Wainwright Cuts Earnings Estimates for Nuvectis Pharma  Defense World Fri, 07 Nov 2025 06:53:26 GMT
 Roth Capital Expects Lower Earnings for Nuvectis Pharma  Defense World Fri, 07 Nov 2025 06:53:21 GMT
 Insider Buying: Ron Bentsur Acquires Additional Shares of Nuvect  GuruFocus Thu, 06 Nov 2025 14:08:40 GMT
 Nuvectis Pharma director Sanchez buys $75k in NVCT stock  Investing.com Thu, 06 Nov 2025 13:27:41 GMT
 Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240  Investing.com Thu, 06 Nov 2025 13:27:40 GMT
 Nuvectis Pharma chairman Bentsur buys $28,600 in shares  Investing.com Thu, 06 Nov 2025 13:25:06 GMT
 nuvectis pharma executives increase their holdings  TradingView Thu, 06 Nov 2025 13:10:00 GMT
 [form 4] nuvectis pharma, inc. insider trading activity  Stock Titan Thu, 06 Nov 2025 13:00:38 GMT
 FY2029 EPS Estimates for Nuvectis Pharma Boosted by Analyst  Defense World Thu, 06 Nov 2025 07:47:18 GMT
 Nuvectis Pharma Grows Its Cash Pile While Chasing Cancer Trials  Finimize Wed, 05 Nov 2025 13:42:46 GMT
 nuvectis pharma reports q3 eps (44c), consensus (25c)  MSN Wed, 05 Nov 2025 12:37:29 GMT
 Nuvectis Pharma Doubles Down On R&D Despite Rising Losses  Finimize Wed, 05 Nov 2025 09:48:52 GMT
 sanchez juan insider trades  Nasdaq Wed, 05 Nov 2025 08:00:00 GMT
 nuvectis pharma reports progress in oncology drug development  TipRanks Wed, 05 Nov 2025 05:05:44 GMT
 Nuvectis Pharma reports Q3 net loss $7.5M vs $4.2M last year  TipRanks Wed, 05 Nov 2025 01:40:40 GMT
 nuvectis pharma grows its cash pile while chasing cancer trials  Finimize Tue, 04 Nov 2025 17:09:20 GMT
 nuvectis pharma doubles down on r&d despite rising losses  Finimize Tue, 04 Nov 2025 15:49:02 GMT
 nuvectis pharma q3 net loss widens on milestone expenses  MarketScreener Tue, 04 Nov 2025 13:25:47 GMT
 nuvectis pharma reports q3 eps (44c), consensus (25c)  TipRanks Tue, 04 Nov 2025 13:23:38 GMT
 nuvectis pharma, inc. sec 10-q report  TradingView Tue, 04 Nov 2025 13:03:00 GMT
 nuvectis pharma | 10-q: q3 2025 earnings report  富途牛牛 Tue, 04 Nov 2025 13:02:13 GMT
 nuvectis pharma q3 net loss widens  MarketScreener Tue, 04 Nov 2025 12:47:59 GMT
 nuvectis pharma reports progress in oncology drug development  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 nuvectis pharma shares: poised for significant growth?  AD HOC NEWS Sat, 01 Nov 2025 17:12:04 GMT
 nuvectis pharma : initial statement of beneficial ownership (form 3)  MarketScreener Fri, 31 Oct 2025 12:02:06 GMT
 [form 4] nuvectis pharma, inc. insider trading activity  Stock Titan Fri, 31 Oct 2025 07:00:00 GMT
 major investment alert: insider buys big in nuvectis pharma!  TipRanks Thu, 30 Oct 2025 02:41:18 GMT
 Nuvectis Pharma Stock (NVCT) Opinions on NXP900 Trial Results  Quiver Quantitative Wed, 29 Oct 2025 07:00:00 GMT
 Major Investment Alert: Insider Buys Big in Nuvectis Pharma!  TipRanks Wed, 29 Oct 2025 07:00:00 GMT
 insider stock purchases: october 29, 2025  Quiver Quantitative Wed, 29 Oct 2025 07:00:00 GMT
 [form 4] nuvectis pharma, inc. insider trading activity  Stock Titan Wed, 29 Oct 2025 07:00:00 GMT

Nuvectis Pharma Inc
(NASDAQ:NVCT) 

NVCT stock logo

Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.

Founded: 2020
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends